ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean

ClinicalTrials.gov ID: NCT03364491

Public ClinicalTrials.gov record NCT03364491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 3:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial

Study identification

NCT ID
NCT03364491
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
The George Washington University Biostatistics Center
Other
Enrollment
11,000 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Tranexamic Acid Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 14, 2018
Primary completion
Jul 23, 2021
Completion
Oct 28, 2021
Last update posted
Feb 20, 2023

2018 – 2021

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
University of Alabama - Birmingham Birmingham Alabama 35233
Northwestern University-Prentice Hospital Chicago Illinois 60611
Columbia University New York New York 10032
University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599
Case Western Reserve-MetroHealth Cleveland Ohio 44109
Ohio State University Hospital Columbus Ohio 43210
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Magee Women's Hospital of UPMC Pittsburgh Pennsylvania 15213
Brown University Providence Rhode Island 02905
University of Texas Medical Branch Galveston Texas 77555
University of Texas - Houston Houston Texas 77030
University of Utah Medical Center Salt Lake City Utah 84132

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03364491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2023 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03364491 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →